ODTX

$23.64-12.35%

Odyssey Therapeutics, Inc.

Market Cap

$1.2B

Sector

Materials

Industry

Biotechnology

Beta

—

Insufficient price history

Price Chart

Loading…

Signals

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro →

Buy Activity

Buy Velocity Score

28.33x

Current Rate (90d)

46486.41/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

Sell Activity

Sell Velocity Score

23.98x

Sell Rate (90d)

19.78/mo

Sell Baseline

0.00/mo

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-05-11	2026-05-13	TPG GP A, LLC	Former 10% Owner	Purchase	1.39M	$18.00	$25.00M	3.69M	View
2026-05-08	2026-05-12	Dimension Capital II, L.P.	Director	Purchase	1.11M	$18.00	$20.00M	3.33M	View
2026-05-11	2026-05-11	Chu Shelley	Director	Purchase	11.1K	$18.00	$200K	11.1K	View
2026-05-11	2026-05-11	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	Sale	1,780	$18.00	$32K	441.0K	View
2026-05-11	2026-05-11	SR ONE CAPITAL MANAGEMENT, LLC	10% Owner	Purchase	555.6K	$18.00	$10.00M	1.83M	View

1–5 of 8

1 / 2

Recent News

Odyssey Therapeutics to Participate in Upcoming Investor Conferences

Yahoo Finance · 2026-08-26

Odyssey Therapeutics (ODTX) Looks Fully Valued As Earnings And Evotec Deal Refocus Attention

Yahoo Finance · 2026-08-11

Evotec and Odyssey collaborate on AI-enabled R&D

Yahoo Finance · 2026-08-07

Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Yahoo Finance · 2026-08-04

Informational purposes only, not investment advice.